Usv Pvt Ltd
General
Total Cases13
Active Cases3
Patents11
Ratings
Experience
Grade
Trend
DCT
L1
D
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 01/23/25 | NOTICE of Appearance by J. BRUGH LOWER on behalf of MERCK SHARP & DOHME B.V., MERCK SHARP & DOHME LLC (LOWER, J.) (Entered: 01/23/2025) | |
| 01/23/25 | Corporate Disclosure Statement by MERCK SHARP & DOHME B.V., MERCK SHARP & DOHME LLC. (DENI, WILLIAM) (Entered: 01/23/2025) | |
| 01/23/25 | COMPLAINT against USV PRIVATE LIMITED ( Filing and Admin fee $ 405 receipt number ANJDC-15962683) , Related Case Selected, filed by MERCK SHARP & DOHME B.V., MERCK SHARP & DOHME LLC. (Attachments: # [1] Exhibit A, # [2] Exhibit B, # [3] Exhibit C, # [4] Exhibit D, # [5] Exhibit E, # [6] Civil Cover Sheet, # [7] L. Civ. R. 11.2 & 40.1 Certification)(DENI, WILLIAM) (Entered: 01/23/2025) | |
| 10/08/24 | STIPULATION to Extend Time - filed by Hetero Labs Limited. (Dorsney, Kenneth) Modified on 10/8/2024 (nms). (Entered: 10/08/2024) | |
| 10/08/24 | SO ORDERED, re [316] STIPULATION to Extend Time (*Reset Answer Deadlines: Hetero Labs Limited answer due 10/23/2024). Signed by Judge Richard G. Andrews on 10/8/2024. (nms) (Entered: 10/08/2024) | |
| 10/04/24 | NOTICE of Voluntary Dismissal by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc. as to U.S. Patent 9,415,053 Counterclaims (Vrana, Robert) (Entered: 10/04/2024) | |
| 09/27/24 | STIPULATION and Proposed Order to Extend Time - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 9/27/2024 (nms). (Entered: 09/27/2024) | |
| 09/27/24 | SO ORDERED, re [314] STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Taro Pharmaceutical Industries, Ltd. answer due 10/11/2024; Taro Pharmaceuticals U.S.A., Inc. answer due 10/11/2024). Signed by Judge Richard G. Andrews on 9/27/2024. (nms) (Entered: 09/27/2024) | |
| 09/24/24 | STIPULATION to Extend Time - filed by Hetero Labs Limited. (Dorsney, Kenneth) Modified on 9/24/2024 (nms). (Entered: 09/24/2024) | |
| 09/24/24 | REDACTED VERSION of [309] Stipulation, by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) Modified on 9/24/2024 (nms). (Entered: 09/24/2024) |